| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.
|
Eur J Pharmacol
|
2002
|
1.26
|
|
2
|
Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system.
|
Eur J Pharmacol
|
2003
|
1.11
|
|
3
|
Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys.
|
Life Sci
|
2004
|
0.89
|
|
4
|
[Effect of TRK-820, a selective kappa opioid receptor agonist, on scratching behavior in an animal model of atopic dermatitis].
|
Nihon Shinkei Seishin Yakurigaku Zasshi
|
2008
|
0.86
|
|
5
|
Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride.
|
Eur J Pharmacol
|
2005
|
0.83
|
|
6
|
Ochratoxin A Contamination of Red Chili Peppers from Chile, Bolivia and Peru, Countries with a High Incidence of Gallbladder Cancer.
|
Asian Pac J Cancer Prev
|
2015
|
0.79
|
|
7
|
Aflatoxin contamination of red chili pepper from Bolivia and Peru, countries with high gallbladder cancer incidence rates.
|
Asian Pac J Cancer Prev
|
2012
|
0.77
|
|
8
|
Suppression of acute herpetic pain-related responses by the kappa-opioid receptor agonist (-)-17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-beta-[n-methyl-3-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (TRK-820) in mice.
|
J Pharmacol Exp Ther
|
2004
|
0.76
|
|
9
|
Mutagenicity and mutagens of the red chili pepper as gallbladder cancer risk factor in Chilean women.
|
Asian Pac J Cancer Prev
|
2011
|
0.76
|
|
10
|
Scratching behavior of ICR-derived glomerulonephritis (ICGN) mice.
|
J Vet Med Sci
|
2010
|
0.75
|
|
11
|
Lack of an Apparent Association between Mycotoxin Concentrations in Red Chili Peppers and Incidence of Gallbladder Cancer in India : an Ecological Study.
|
Asian Pac J Cancer Prev
|
2016
|
0.75
|
|
12
|
In vitro and in vivo pharmacological characterization of the main metabolites of nalfurafine hydrochloride.
|
Eur J Pharmacol
|
2012
|
0.75
|